Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.49M Buy
127,500
+60,900
+91% +$3.08M ﹤0.01% 2147
2026
Q2
$4.09M Buy
66,600
+43,300
+186% +$2.65M ﹤0.01% 2318
2026
Q1
$1.62M Sell
23,300
-29,300
-56% -$2.26M ﹤0.01% 2783
2025
Q4
$4M Buy
+52,600
New +$4.22M ﹤0.01% 1895
2025
Q3
– Sell
-73,400
Closed -$5.01M – 3582
2025
Q2
$5.01M Buy
73,400
+4,700
+7% +$291K ﹤0.01% 1388
2025
Q1
$4.09M Sell
68,700
-58,900
-46% -$3.73M ﹤0.01% 1339
2024
Q4
$7.72M Buy
127,600
+35,300
+38% +$2.16M ﹤0.01% 1041
2024
Q3
$6.65M Buy
92,300
+4,100
+5% +$286K ﹤0.01% 1004
2024
Q2
$6.21M Buy
88,200
+62,400
+242% +$4.8M ﹤0.01% 973
2024
Q1
$2.05M Buy
+25,800
New +$2.08M ﹤0.01% 1346

Other funds holding APTV

IMC Chicago's APTV Position: Q3 2026 in Review

IMC Chicago reduced its Aptiv (APTV) stake by 68% in Q3 2026, selling an estimated $2.05M and leaving 19,521 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #4099.

IMC Chicago first reported a position in APTV in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.69M in Q2 2026. 311 funds tracked by Wall St. Rank hold APTV as of Q3 2026.

  • IMC Chicago held 19,521 shares of Aptiv worth $840K as of Q3 2026.
  • IMC Chicago sold 40,620 Aptiv shares in Q3 2026, an estimated $2.05M.
  • Aptiv made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4099 holding.
  • IMC Chicago first reported a position in Aptiv in Q2 2024 and has held it in 5 quarters since.
  • IMC Chicago's Aptiv position peaked at $3.69M in Q2 2026.
  • 311 funds tracked by Wall St. Rank held Aptiv as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.